Henan Lingrui Pharmaceutical Co (SHSE:600285) Beta: 0.4069 (As of Jul. 13, 2026)


SHSE:600285 Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
97 GF Score
Price ¥22.54
GF Value ¥24.39
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Henan Lingrui Pharmaceutical Co Beta?

Henan Lingrui Pharmaceutical Co SHSE:600285 +3.78% 97 Beta is 0.4069 as of Jul. 13, 2026. GuruFocus rates SHSE:600285 with a GF Score™ of 97/100 and a GF Value™ of ¥24.39 (Fairly Valued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-13), Henan Lingrui Pharmaceutical Co's Beta is 0.4069.


Henan Lingrui Pharmaceutical Co  (SHSE:600285) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Henan Lingrui Pharmaceutical Co Beta Related Terms


Henan Lingrui Pharmaceutical Co Beta Historical Data

* Premium members only.

The historical data trend for Henan Lingrui Pharmaceutical Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Lingrui Pharmaceutical Co Beta Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.14 1.23 0.97 0.75 0.48

Henan Lingrui Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.37 0.23 0.48 0.41

SHSE:600285 vs ZTS, UTHR: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Lingrui Pharmaceutical Co Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's Beta distribution charts can be found below:

* The bar in red indicates where Henan Lingrui Pharmaceutical Co's Beta falls into.


SHSE:600285
97GF Score
Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Henan Lingrui Pharmaceutical Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.4069 mean?
Henan Lingrui Pharmaceutical Co (SHSE:600285) has a Beta of 0.4069 as of Jul. 13, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Henan Lingrui Pharmaceutical Co and its competitors.
Is Henan Lingrui Pharmaceutical Co's Beta too high?
Henan Lingrui Pharmaceutical Co's current Beta is 0.4069. Overall, Henan Lingrui Pharmaceutical Co has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henan Lingrui Pharmaceutical Co's Beta compare to ZTS and UTHR?
Henan Lingrui Pharmaceutical Co's Beta of 0.4069 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Henan Lingrui Pharmaceutical Co and its competitors. Henan Lingrui Pharmaceutical Co's current Beta is 0.4069. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Lingrui Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co (SHSE:600285) is currently considered Fairly Valued. The stock's GF Value™ is ¥24.39, compared to a current price of ¥22.54 — trading 7.6% below its estimated fair value. The current Beta is 0.4069. Henan Lingrui Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Henan Lingrui Pharmaceutical Co (SHSE:600285), the current Beta is 0.4069 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?

Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥22.54 is trading 7.6% below its estimated GF Value™ of ¥24.39. GuruFocus considers Henan Lingrui Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600285:

  • Beta: 0.4069
  • GF Value™: ¥24.39 vs. price of ¥22.54 (7.6% below fair value)
  • GF Score™: 97/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Henan Lingrui Pharmaceutical Co Business Description

Address No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
97GF Score

Get the complete analysis for SHSE:600285

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥22.54
Price
¥24.39
GF Value